Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fospropofol effective dose for postoperative ICU mechanical ventilation sedation
ChiCTR2200057111Phase 4Not yet recruiting
- Sponsor
- Union Hospital
- Start
- Mar 2022
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of fospropofol disodium in postoperative recovery and respiratory failure (5 arms), sponsored by Union Hospital. Primary endpoint: Effective dose of fospropofol for postoperative patient sedation. Planned start Mar 2022; status: not yet recruiting.
02
Drugs
fospropofol disodium
03
Conditions
postoperative recoveryrespiratory failure
Beyond the preview
Go deeper on ChiCTR2200057111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200057111.